Display options
Cite
Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon). 2014;42(12):698-702doi: 10.1016/j.mpmed.2014.09.007.
Forouhi, N. G., & Wareham, N. J. (2014). Epidemiology of diabetes. Medicine (Abingdon, England : UK ed.), 42(12), 698-702. https://doi.org/10.1016/j.mpmed.2014.09.007
Forouhi, Nita Gandhi, and Wareham, Nicholas J. "Epidemiology of diabetes." Medicine (Abingdon, England : UK ed.) vol. 42,12 (2014): 698-702. doi: https://doi.org/10.1016/j.mpmed.2014.09.007
Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon). 2014 Dec;42(12):698-702. doi: 10.1016/j.mpmed.2014.09.007. PMID: 25568613; PMCID: PMC4282306.
Copy Download .nbib Format: NLM
Share it on

Medicine (Abingdon). 2014 Dec;42(12):698-702. doi: 10.1016/j.mpmed.2014.09.007.

Epidemiology of diabetes.

Medicine (Abingdon, England : UK ed.)

Nita Gandhi Forouhi, Nicholas J Wareham

Affiliations

  1. is Programme Leader and Honorary Public Health Physician at the MRC Epidemiology Unit, University of Cambridge, UK. Competing interests: none declared.

PMID: 25568613 PMCID: PMC4282306 DOI: 10.1016/j.mpmed.2014.09.007

Abstract

The disease burden related to diabetes is high and rising in every country, fuelled by the global rise in the prevalence of obesity and unhealthy lifestyles. The latest estimates show a global prevalence of 382 million people with diabetes in 2013, expected to rise to 592 million by 2035. The aetiological classification of diabetes has now been widely accepted. Type 1 and type 2 diabetes are the two main types, with type 2 diabetes accounting for the majority (>85%) of total diabetes prevalence. Both forms of diabetes can lead to multisystem complications of microvascular endpoints, including retinopathy, nephropathy and neuropathy, and macrovascular endpoints including ischaemic heart disease, stroke and peripheral vascular disease. The premature morbidity, mortality, reduced life expectancy and financial and other costs of diabetes make it an important public health condition.

Keywords: Aetiology; diagnosis; epidemiology; prevention; screening; type 1 diabetes; type 2 diabetes

References

  1. Diabet Med. 2006 Feb;23(2):189-97 - PubMed
  2. Lancet. 2011 Jul 9;378(9786):156-67 - PubMed
  3. Lancet. 2012 Nov 17;380(9855):1741-8 - PubMed
  4. Diabet Med. 2007 Feb;24(2):200-7 - PubMed
  5. BMJ. 2012 Nov 01;345:e7293 - PubMed
  6. Prev Med. 2006 May;42(5):364-8 - PubMed
  7. Diabetologia. 2013 Jul;56(7):1520-30 - PubMed
  8. JAMA. 2007 Sep 26;298(12):1420-8 - PubMed
  9. Diabetologia. 2014 Feb;57(2):321-33 - PubMed
  10. Lancet. 2001 Nov 3;358(9292):1500-3 - PubMed
  11. JAMA. 2001 Apr 25;285(16):2109-13 - PubMed
  12. Diabet Med. 2009 Jul;26(7):673-8 - PubMed
  13. BMJ. 2007 Feb 10;334(7588):299 - PubMed
  14. Diabetologia. 2013 Jan;56(1):47-59 - PubMed
  15. Diabetes. 2011 May;60(5):1624-31 - PubMed
  16. Lancet. 2009 Jun 13;373(9680):2027-33 - PubMed
  17. JAMA. 2014 May 7;311(17):1778-86 - PubMed
  18. Diabet Med. 2006 Aug;23(8):857-66 - PubMed
  19. Diabetologia. 2001 Jan;44(1):3-15 - PubMed
  20. PLoS Med. 2014 May 20;11(5):e1001647 - PubMed
  21. Nat Genet. 2012 Sep;44(9):981-90 - PubMed
  22. Eur J Clin Nutr. 2012 Oct;66(10):1082-92 - PubMed
  23. Diabetologia. 2014 May;57(5):909-17 - PubMed

Publication Types

Grant support